These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21692671)

  • 1. Vancomycin dosing and monitoring 2 years after the guidelines.
    Lomaestro BM
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):657-67. PubMed ID: 21692671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
    Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin: a 50-something-year-old antibiotic we still don't understand.
    Schilling A; Neuner E; Rehm SJ
    Cleve Clin J Med; 2011 Jul; 78(7):465-71. PubMed ID: 21724929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient.
    Norazah A; Salbiah N; Nurizzat M; Santhana R
    Med J Malaysia; 2009 Jun; 64(2):166-7. PubMed ID: 20058580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006
    [No Abstract]   [Full Text] [Related]  

  • 7. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
    Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].
    Lepe JA; Gil-Navarro MV; Santos-Rubio MD; Bautista J; Aznar J
    Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of continuous-infusion vancomycin.
    DiMondi VP; Rafferty K
    Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin: we can't get there from here.
    Patel N; Pai MP; Rodvold KA; Lomaestro B; Drusano GL; Lodise TP
    Clin Infect Dis; 2011 Apr; 52(8):969-74. PubMed ID: 21460308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?
    Veer P; Chande C; Chavan S; Wabale V; Chopdekar K; Bade J; Joshi A
    Indian J Med Microbiol; 2010; 28(4):413-4. PubMed ID: 20966589
    [No Abstract]   [Full Text] [Related]  

  • 15. New target concentrations for vancomycin in Hong Kong.
    You JH; Chow SS; Lui JW; Ip M
    Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378
    [No Abstract]   [Full Text] [Related]  

  • 16. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
    Golden M; Shaib W; Havill N
    Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.
    Liu C; Bayer A; Cosgrove SE; Daum RS; Fridkin SK; Gorwitz RJ; Kaplan SL; Karchmer AW; Levine DP; Murray BE; J Rybak M; Talan DA; Chambers HF
    Clin Infect Dis; 2011 Feb; 52(3):285-92. PubMed ID: 21217178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
    Kullar R; Davis SL; Levine DP; Rybak MJ
    Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.